| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:3097-3101.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Cardiology (R.J.H., J.B.S., A.F.M., D.A.S.G.M.) and Diabetes & Endocrinology (E.M.S., S.G.G.), St Jamess University Hospital, Leeds, United Kingdom.
Correspondence to Dr R.J. Huggett, Department of Cardiology, St Jamess University Hospital, Beckett St, Leeds LS9 7TF, United Kingdom. E-mail roberthuggett{at}hotmail.com
Received April 3, 2003; de novo received July 18, 2003; revision received September 19, 2003; accepted September 22, 2003.
Background Essential hypertension (EHT) is a major cardiovascular risk factor, and the additional presence of type 2 diabetes mellitus (DM2) increases this risk. However, although the sympathetic nerve hyperactivity of EHT is known to play a role in cardiovascular risk, the level of sympathetic nerve activity is known neither in DM2 nor in hypertensive type 2 diabetic patients (EHT+DM2). Therefore, we planned to quantify the vasoconstrictor sympathetic nerve activity in patients with EHT+DM2 and with DM2 relative to that in matched groups with EHT and normal blood pressure (NT).
Methods and Results In 68 closely matched subjects with EHT+DM2 (n=17), DM2 (n=17), EHT (n=17), and NT (n=17), we measured resting muscle sympathetic nerve activity as the mean frequency of multiunit bursts (MSNA) and of single units (s-MSNA) with defined vasoconstrictor properties. The s-MSNA in EHT+DM2 (97±3.8 impulses/100 beats) was greater (at least P<0.001) than in EHT (69±3.4 impulses/100 beats) and DM2 (78±4.1 impulses/100 beats), and all these were significantly greater (at least P<0.01) than in NT (53±3.3 impulses/100 beats) despite similar age and body mass index. The MSNA followed a similar trend. In addition, the level of insulin was also raised in EHT+DM2 (20.4±3.6 µU/mL) and DM2 (18.1±3.1 µU/mL; at least P<0.05) compared with HT or NT.
Conclusions Patients with EHT+DM2, EHT, or DM2 had central sympathetic hyperactivity, although plasma insulin levels were raised only in EHT+DM2 and DM2. The combination of EHT and DM2 resulted in the greatest sympathetic hyperactivity and level of plasma insulin, and this hyperactivity could constitute a mechanism for the increased risks of this condition.
Key Words: nervous system, sympathetic hypertension diabetes mellitus
This article has been cited by other articles:
![]() |
Y. Ao, N. Toy, M. K. Song, V. L. W. Go, and H. Yang Altered Glucose and Insulin Responses to Brain Medullary Thyrotropin-Releasing Hormone (TRH)-Induced Autonomic Activation in Type 2 Diabetic Goto-Kakizaki Rats Endocrinology, December 1, 2005; 146(12): 5425 - 5432. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension Hypertension, December 1, 2004; 44(6): 847 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bitz, S. Toubro, T. M. Larsen, H. Harder, K. L. Rennie, S. A. Jebb, and A. Astrup Increased 24-h Energy Expenditure in Type 2 Diabetes Diabetes Care, October 1, 2004; 27(10): 2416 - 2421. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |